Here's Exactly Why I'm Not Afraid of Pfizer's 6% Dividend Yield
Key PointsPfizer shares have underperformed since 2021, with the recent poor performance reflecting concerns about impending patent expirations.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.